Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis

Jeffrey M. Hardacre, Christine A. Iacobuzio-Donahue, Taylor A. Sohn, Susan C. Abraham, Charles J. Yeo, Keith D. Lillemoe, Michael A. Choti, Kurtis A. Campbell, Richard D. Schulick, Ralph H. Hruban, John L. Cameron, Steven D. Leach, William H. Nealon, Thomas R. Gadacz, Leslie H. Blumgart

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Objective: To compare the presentation and short-term results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis (LPSP) and pancreatic adenocarcinoma (PA) and to provide long-term follow-up on patients undergoing resection for LPSP. Summary Background Data: LPSP is a rare form of chronic pancreatitis characterized by a mixed inflammatory infiltrate centered around pancreatic ducts and ductules, combined with obliterative phlebitis. Its presentation may mimic that of PA. Methods Among 1,648 patients undergoing pancreaticoduodenectomy at the authors' institution from January 1992 to May 2002, 37 with LPSP were identified. The demographics, clinical features, and short- and long-term outcomes of these patients were analyzed. Where applicable, comparisons were made to a consecutive group of 45 patients who underwent pancreaticoduodenectomy for PA from July 2001 to December 2001. Results: Twenty-four percent (9/37) of the LPSP patients and none of the PA patients had a history of either atopic or autoimmune disease. The LPSP patients had a similar clinical presentation to the PA patients, but the LPSP patients were less likely to have a discrete pancreatic mass on CT and more likely to have CT findings suggesting a diffusely enlarged pancreas. The LPSP patients were also less likely to have a discrete pancreatic mass at operation, more likely to have a diffusely firm or hard gland, and more likely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patients. Transfusion requirement, operative time, postoperative length of stay, and overall complication rate were similar between groups; however, the LPSP patients had a greater operative blood loss. The median length of follow-up for LPSP patients was 33 months. No patients had recurrent jaundice. One patient with LPSP had clinically evident recurrent pancreatitis. Among LPSP patients available for current telephone interview, 68% subjectively rated their quality of life as better, 18% reported no change, and 14% reported diminished quality of life compared to before surgery. Conclusion: LPSP mimics PA in clinical presentation, though CT findings of a diffusely enlarged pancreas without a discrete mass may suggest a diagnosis of LPSP. Nevertheless, differentiation from pancreatic neoplasia remains difficult. Patients undergoing pancreaticoduodenectomy for LPSP have durable relief of symptoms and a subjectively improved quality of life.

Original languageEnglish (US)
Pages (from-to)853-859
Number of pages7
JournalAnnals of Surgery
Volume237
Issue number6
DOIs
StatePublished - Jun 2003
Externally publishedYes

Fingerprint

Pancreaticoduodenectomy
Pancreatitis
Adenocarcinoma
Quality of Life
Pancreas
Phlebitis
Mesenteric Veins
Pancreatic Ducts
Chronic Pancreatitis
Operative Time
Portal Vein

ASJC Scopus subject areas

  • Surgery

Cite this

Hardacre, J. M., Iacobuzio-Donahue, C. A., Sohn, T. A., Abraham, S. C., Yeo, C. J., Lillemoe, K. D., ... Blumgart, L. H. (2003). Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis. Annals of Surgery, 237(6), 853-859. https://doi.org/10.1097/00000658-200306000-00014

Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis. / Hardacre, Jeffrey M.; Iacobuzio-Donahue, Christine A.; Sohn, Taylor A.; Abraham, Susan C.; Yeo, Charles J.; Lillemoe, Keith D.; Choti, Michael A.; Campbell, Kurtis A.; Schulick, Richard D.; Hruban, Ralph H.; Cameron, John L.; Leach, Steven D.; Nealon, William H.; Gadacz, Thomas R.; Blumgart, Leslie H.

In: Annals of Surgery, Vol. 237, No. 6, 06.2003, p. 853-859.

Research output: Contribution to journalArticle

Hardacre, JM, Iacobuzio-Donahue, CA, Sohn, TA, Abraham, SC, Yeo, CJ, Lillemoe, KD, Choti, MA, Campbell, KA, Schulick, RD, Hruban, RH, Cameron, JL, Leach, SD, Nealon, WH, Gadacz, TR & Blumgart, LH 2003, 'Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis', Annals of Surgery, vol. 237, no. 6, pp. 853-859. https://doi.org/10.1097/00000658-200306000-00014
Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD et al. Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis. Annals of Surgery. 2003 Jun;237(6):853-859. https://doi.org/10.1097/00000658-200306000-00014
Hardacre, Jeffrey M. ; Iacobuzio-Donahue, Christine A. ; Sohn, Taylor A. ; Abraham, Susan C. ; Yeo, Charles J. ; Lillemoe, Keith D. ; Choti, Michael A. ; Campbell, Kurtis A. ; Schulick, Richard D. ; Hruban, Ralph H. ; Cameron, John L. ; Leach, Steven D. ; Nealon, William H. ; Gadacz, Thomas R. ; Blumgart, Leslie H. / Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis. In: Annals of Surgery. 2003 ; Vol. 237, No. 6. pp. 853-859.
@article{b85f2cbf24fd4873b95a4d7279b15881,
title = "Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis",
abstract = "Objective: To compare the presentation and short-term results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis (LPSP) and pancreatic adenocarcinoma (PA) and to provide long-term follow-up on patients undergoing resection for LPSP. Summary Background Data: LPSP is a rare form of chronic pancreatitis characterized by a mixed inflammatory infiltrate centered around pancreatic ducts and ductules, combined with obliterative phlebitis. Its presentation may mimic that of PA. Methods Among 1,648 patients undergoing pancreaticoduodenectomy at the authors' institution from January 1992 to May 2002, 37 with LPSP were identified. The demographics, clinical features, and short- and long-term outcomes of these patients were analyzed. Where applicable, comparisons were made to a consecutive group of 45 patients who underwent pancreaticoduodenectomy for PA from July 2001 to December 2001. Results: Twenty-four percent (9/37) of the LPSP patients and none of the PA patients had a history of either atopic or autoimmune disease. The LPSP patients had a similar clinical presentation to the PA patients, but the LPSP patients were less likely to have a discrete pancreatic mass on CT and more likely to have CT findings suggesting a diffusely enlarged pancreas. The LPSP patients were also less likely to have a discrete pancreatic mass at operation, more likely to have a diffusely firm or hard gland, and more likely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patients. Transfusion requirement, operative time, postoperative length of stay, and overall complication rate were similar between groups; however, the LPSP patients had a greater operative blood loss. The median length of follow-up for LPSP patients was 33 months. No patients had recurrent jaundice. One patient with LPSP had clinically evident recurrent pancreatitis. Among LPSP patients available for current telephone interview, 68{\%} subjectively rated their quality of life as better, 18{\%} reported no change, and 14{\%} reported diminished quality of life compared to before surgery. Conclusion: LPSP mimics PA in clinical presentation, though CT findings of a diffusely enlarged pancreas without a discrete mass may suggest a diagnosis of LPSP. Nevertheless, differentiation from pancreatic neoplasia remains difficult. Patients undergoing pancreaticoduodenectomy for LPSP have durable relief of symptoms and a subjectively improved quality of life.",
author = "Hardacre, {Jeffrey M.} and Iacobuzio-Donahue, {Christine A.} and Sohn, {Taylor A.} and Abraham, {Susan C.} and Yeo, {Charles J.} and Lillemoe, {Keith D.} and Choti, {Michael A.} and Campbell, {Kurtis A.} and Schulick, {Richard D.} and Hruban, {Ralph H.} and Cameron, {John L.} and Leach, {Steven D.} and Nealon, {William H.} and Gadacz, {Thomas R.} and Blumgart, {Leslie H.}",
year = "2003",
month = "6",
doi = "10.1097/00000658-200306000-00014",
language = "English (US)",
volume = "237",
pages = "853--859",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Results of Pancreaticoduodenectomy for Lymphoplasmacytic Sclerosing Pancreatitis

AU - Hardacre, Jeffrey M.

AU - Iacobuzio-Donahue, Christine A.

AU - Sohn, Taylor A.

AU - Abraham, Susan C.

AU - Yeo, Charles J.

AU - Lillemoe, Keith D.

AU - Choti, Michael A.

AU - Campbell, Kurtis A.

AU - Schulick, Richard D.

AU - Hruban, Ralph H.

AU - Cameron, John L.

AU - Leach, Steven D.

AU - Nealon, William H.

AU - Gadacz, Thomas R.

AU - Blumgart, Leslie H.

PY - 2003/6

Y1 - 2003/6

N2 - Objective: To compare the presentation and short-term results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis (LPSP) and pancreatic adenocarcinoma (PA) and to provide long-term follow-up on patients undergoing resection for LPSP. Summary Background Data: LPSP is a rare form of chronic pancreatitis characterized by a mixed inflammatory infiltrate centered around pancreatic ducts and ductules, combined with obliterative phlebitis. Its presentation may mimic that of PA. Methods Among 1,648 patients undergoing pancreaticoduodenectomy at the authors' institution from January 1992 to May 2002, 37 with LPSP were identified. The demographics, clinical features, and short- and long-term outcomes of these patients were analyzed. Where applicable, comparisons were made to a consecutive group of 45 patients who underwent pancreaticoduodenectomy for PA from July 2001 to December 2001. Results: Twenty-four percent (9/37) of the LPSP patients and none of the PA patients had a history of either atopic or autoimmune disease. The LPSP patients had a similar clinical presentation to the PA patients, but the LPSP patients were less likely to have a discrete pancreatic mass on CT and more likely to have CT findings suggesting a diffusely enlarged pancreas. The LPSP patients were also less likely to have a discrete pancreatic mass at operation, more likely to have a diffusely firm or hard gland, and more likely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patients. Transfusion requirement, operative time, postoperative length of stay, and overall complication rate were similar between groups; however, the LPSP patients had a greater operative blood loss. The median length of follow-up for LPSP patients was 33 months. No patients had recurrent jaundice. One patient with LPSP had clinically evident recurrent pancreatitis. Among LPSP patients available for current telephone interview, 68% subjectively rated their quality of life as better, 18% reported no change, and 14% reported diminished quality of life compared to before surgery. Conclusion: LPSP mimics PA in clinical presentation, though CT findings of a diffusely enlarged pancreas without a discrete mass may suggest a diagnosis of LPSP. Nevertheless, differentiation from pancreatic neoplasia remains difficult. Patients undergoing pancreaticoduodenectomy for LPSP have durable relief of symptoms and a subjectively improved quality of life.

AB - Objective: To compare the presentation and short-term results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis (LPSP) and pancreatic adenocarcinoma (PA) and to provide long-term follow-up on patients undergoing resection for LPSP. Summary Background Data: LPSP is a rare form of chronic pancreatitis characterized by a mixed inflammatory infiltrate centered around pancreatic ducts and ductules, combined with obliterative phlebitis. Its presentation may mimic that of PA. Methods Among 1,648 patients undergoing pancreaticoduodenectomy at the authors' institution from January 1992 to May 2002, 37 with LPSP were identified. The demographics, clinical features, and short- and long-term outcomes of these patients were analyzed. Where applicable, comparisons were made to a consecutive group of 45 patients who underwent pancreaticoduodenectomy for PA from July 2001 to December 2001. Results: Twenty-four percent (9/37) of the LPSP patients and none of the PA patients had a history of either atopic or autoimmune disease. The LPSP patients had a similar clinical presentation to the PA patients, but the LPSP patients were less likely to have a discrete pancreatic mass on CT and more likely to have CT findings suggesting a diffusely enlarged pancreas. The LPSP patients were also less likely to have a discrete pancreatic mass at operation, more likely to have a diffusely firm or hard gland, and more likely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patients. Transfusion requirement, operative time, postoperative length of stay, and overall complication rate were similar between groups; however, the LPSP patients had a greater operative blood loss. The median length of follow-up for LPSP patients was 33 months. No patients had recurrent jaundice. One patient with LPSP had clinically evident recurrent pancreatitis. Among LPSP patients available for current telephone interview, 68% subjectively rated their quality of life as better, 18% reported no change, and 14% reported diminished quality of life compared to before surgery. Conclusion: LPSP mimics PA in clinical presentation, though CT findings of a diffusely enlarged pancreas without a discrete mass may suggest a diagnosis of LPSP. Nevertheless, differentiation from pancreatic neoplasia remains difficult. Patients undergoing pancreaticoduodenectomy for LPSP have durable relief of symptoms and a subjectively improved quality of life.

UR - http://www.scopus.com/inward/record.url?scp=0038452600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038452600&partnerID=8YFLogxK

U2 - 10.1097/00000658-200306000-00014

DO - 10.1097/00000658-200306000-00014

M3 - Article

VL - 237

SP - 853

EP - 859

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 6

ER -